Vimarsana
Biggest News Aggregation in the World

Mediated Kidney News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mediated Kidney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mediated Kidney Today - Breaking & Trending Today

Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease - Vimarsana News

Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease

Published: April 1, 2024

Vertex Pharmaceuticals Incorporated today announced that inaxaplin (VX-147) has advanced into the Phase 3 portion of the global Phase 2/3 pivotal clinical trial in APOL1-mediated kidney disease (AMKD), where a 45 mg once daily oral dose will be...

Source: lelezard.com
Related Topics:
City OfUnited KingdomUnited StatesCarmen BozicGlenn ChertowGlennm ChertowVertex Pharmaceuticals Incorporated NasdaqExchange CommissionProduct ServiceProgram Steering CommitteeStanford University School Of MedicineData Monitoring CommitteeDrug AdministrationGlobal Medicines DevelopmentEuropean Medicines AgencyCompanies To WorkAdvances InaxaplinAdaptive PhaseMediated KidneyPharmaceuticals IncorporatedExecutive Vice PresidentMedical AffairsChief Medical OfficerStanford University SchoolIndependent Data Monitoring Committee
3 Top Healthcare Stocks Defying the Bear Market - Vimarsana News

3 Top Healthcare Stocks Defying the Bear Market

Published: November 10, 2022

These healthcare companies haven't been slowed by macroeconomic conditions.

Source: fool.com
Related Topics:
United StatesVertex PharmaceuticalsDrug AdministrationAbbott LaboratoriesOptum HealthUnitedhealth GroupHealth GroupDividend KingMediated Kidney